Versions Compared

Old Version 5

changes.mady.by.user April Seaward

Saved on

compared with

New Version Current

changes.mady.by.user April Seaward

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Ali, F., Russell, C., Nafeh, F., Chaufan, C., Imtiaz, S., Rehm, J., Spafford, A. & Elton-Marshall, T. 2022. Youth substance use service provider's perspectives on use and service access in Ontario: Time to reframe the discourse. Subst Abuse Treat Prev Policy, 17(1):9.

Ferguson, M., Medley, A., Rittenbach, K., Brothers, T.D., Strike, C., Ng, J., Leece, P., Elton-Marshall, T., Ali, F., Lorenzetti, D.L. & Buxton, J.A. 2022. Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method. Harm Reduct J, 19(1):71.

Russell, C., Lange, S., Kouyoumdjian, F., Butler, A. & Ali, F. 2022. Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA? Harm Reduct J, 19(1):89.

Russell, C., Law, J., Bonn, M., Rehm, J. & Ali, F. 2022. The increase in benzodiazepine-laced drugs and related risks in canada: The urgent need for effective and sustainable solutions. Int J Drug Policy, 111:103933.